• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

LUNG CANCER EUROPE IS GROWING STRONGER

Starting September, Alfonso Aguarón (second from left) is LuCE’s new project manager. He has extensive experience in patient advocacy field […]

NEW ESMO TUMOUR DNA SCALE HELPS MATCH PATIENTS WITH CANCER TO OPTIMAL TARGETED MEDICINES

A new scale for tumour DNA mutations which will simplify and standardise choices for targeted cancer treatment has been agreed by […]

THE SOCIETY FOR IMMUNOTHERAPY OF CANCER CONSENSUS STATEMENT ON IMMUNOTHERAPY FOR THE TREATMENT OF NSCLC

Due to the distinct features of cancer immunotherapy, and rapid progress in the field, clinical guidance is needed on the […]

IASLC ISSUES STATEMENT PAPER ON LIQUID BIOPSY FOR LUNG CANCER

The lungs can be a difficult organ to biopsy with a needle, so the promise of identifying lung cancer through […]

ECCO LAUNCHED ACCESS TO INNOVATION PAPER

ECCO and its members have now set out a manifesto for improved access to innovation in a consensus paper published in […]

LUCE AT ASCO 2018 – LUNG CANCER SCREENING

LuCE members Walce Onlus & Fundacion Mas Que Ideas attended the American Society of Clinical Oncology (ASCO) Annual Meeting. They talked with MD […]

LUCE AT ASCO 2018 – LUNG CANCER HIGHLIGHTS

Prof. Giulio Scagliotti talked about lungcancer highlights with Stefania Vallone, LuCE president and Diego Villalón, LuCE member. Topics focused on new treatment […]

LUCE WEBINAR “HOW TO GET PUBLIC ATTENTION ON A RELEVANT TOPIC”

LuCE latest webinar focused on how your can get higher public influence. Anna Wagstaff, editor of Cancer World (ESO Magazine) […]

2018 AGM SOFIA

LuCE Board 2018 Between the 20th and the 22nd April, LuCE organized the annual AGM in Sofia. The event being […]

2017 LUCE TRANSLATED REPORT

During latest LuCE Report launching event, Stefania Vallone, LuCE’s President encouraged the attendees to give a step forward, and try […]